Luke Evnin, Director at Werewolf Therapeutics, Inc. (HOWL), sold 78,377 shares at $0.61 ($48K) on 2025-12-30, disclosed to the SEC on 2026-01-02.
Open-market sale of $48k HOWL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.61 | 34,847 | $21K | 43.9% |
| 2 | $0.62 | 24,962 | $15K | 32.0% |
| 3 | $0.63 | 18,568 | $12K | 24.2% |
| Total | $0.62 avg | 78,377 | $48K | 100% |
| Filing → |
| HOWL | SELL | 2026-06-10 | $28K | — | Filing → |
| HOWL | SELL | 2026-06-08 | $43K | — | Filing → |
| HOWL | SELL | 2026-06-03 | $64K | — | Filing → |